Concepedia

Irmgard Bumeder

IB

11

Publications

628

Citations

11

H-Index

2003

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

München Klinik Schwabing

LMU Klinikum

München Klinik

Universität Ulm

Irmgard Bumeder is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

2003–2017

11

Publications

11

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Markus V. Heppt, Lucie Heinzerling, Katharina C. Kähler et al. · European Journal of Cancer · 2017 · 196 citations

, , +9

Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells

Philipp Baumann, Sonja Mandl–Weber, Andreas Völkl et al. · Molecular Cancer Therapeutics · 2009 · 112 citations

First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma

Ralf Schmidmaier, Philipp Baumann, Irmgard Bumeder et al. · European Journal Of Haematology · 2007 · 70 citations

Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?

Eckhard Frick, C. Motzke, N. Fischer et al. · Psycho-Oncology · 2005 · 65 citations

Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation

Eckhard Frick, Gian Domenico Borasio, H. Zehentner et al. · Psycho-Oncology · 2003 · 54 citations

Rows per page

1–5 of 11